arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC
$1.34 ▼ -0.03 (-2.54%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
66 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

NEUROONE MEDICAL TECHNOLOGIES Corp faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $11.6M
Dividend Yield —
Revenue Growth 16.3% ↘
Op. Margin -122.9% ↘
ROIC -50.8% ↘
FCF / Share $-0.13 ↗
Trailing P/E —
Price / Book 3.1x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

66-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.97M
↑ +16.3% —
Net Income Profit after all expenses
$-1.44M
— 0.0% —
Operating Margin Operating profit as % of sales
-122.9%
↓ -39.8% 5th
FCF / Share Free cash flow per share
$-0.13
↑ +21.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
6
Returns
16
Cash Quality ↓
54

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 16 years · 66 quarters